RFK Jr. urges closing food additive loophole
RFK Jr. urges closing a loophole that lets food companies bypass safety checks for certain additives. Critics argue proposed fixes remain too weak to protect public health from potentially harmful suโฆ
Robert F. Kennedy Jr. is calling for a fix to a loophole that lets food companies add certain additives without oversight after the Trump administration announced new steps to tighten rules. The FDAโs 2021 rule removed preโmarket approval for โnonโingredientโ additives, a category that includes dyes, preservatives and flavor enhancers. The loophole has allowed companies to introduce dozens of new substances each year, often without the safety data that would normally be required.
The issue matters because the additives that slip through the cracks can affect millions of Americans. Health experts warn that some of the substances added this way may trigger allergies, disrupt hormones or increase cancer risk. The FDAโs oversight has been criticized for being too slow and too focused on โingredientsโ rather than the full range of chemicals that can end up in food. RFK Jr., a longโtime critic of the agency, argues that the current framework lets powerful food corporations skirt safety checks that were in place before the 2021 rule.
The Trump administrationโs announcement is a modest step. It says it will review the rule and consider new regulations that could close the gap. Industry groups say the proposed changes are too narrow, targeting only a handful of additives and leaving many others exempt. Consumer advocates point out that the FDAโs proposed rule would still allow companies to add new additives by simply labeling them as โfood ingredients,โ a move that could bypass the current safety testing requirements. The FDA is expected to open a public comment period next month and issue a final rule by the end of the year, but many experts warn that the changes may not be enough to protect public health.
If the final rule is adopted, it could raise the cost of bringing new additives to market and slow down product innovation, but it would also give the FDA more power to evaluate safety before products reach shelves. The debate highlights a broader tension between deregulation and consumer protection. For many consumers, the outcome will determine how much
Read Full Story at NBC News โ


